OLIVIA COX: Open Payments
NPI 1477063873 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,706 in 129 payments from 25 companies in 2025. Trend: 2023 $3,072 · 2024 $2,702 · 2025 $2,706
Food & beverage: $2,706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $674 |
| TG Therapeutics, Inc. | 14 | $474 |
| Novartis Pharmaceuticals Corporation | 15 | $285 |
| Amgen Inc. | 12 | $203 |
| UCB, Inc. | 5 | $138 |
| Neurelis, Inc. | 2 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $93 |
| Biogen, Inc. | 4 | $87 |
| CSL Behring | 3 | $64 |
| Amneal Pharmaceuticals LLC | 3 | $64 |
Products named: BRIUMVI, KESIMPTA, UBRELVY, QULIPTA, BOTOX, UPLIZNA, VALTOCO, HYQVIA.
Industry payments across AR — which companies pay providers there.
